Among the results and success stories of the SATTs published in the 2019 Success Book, find Ermium Therapeutics, a biotech company developing innovative therapies for auto-immune diseases, based on a breakthrough discovery showing that CXCR4 is a master regulator of inflammation.
➔ Consult the SATT 2019 Sucess Book (Ermium Therapeutics page 17, french version)
➔ Consult the SATT Network website
